This study is also due to start soon and the planning stages have recently been finished. The compound being tested is alpha fetoprotein, a hormone that is naturally present and rises in pregnancy. It has long been noted that uveitis and other autoimmune diseases improve during the later stages of pregnancy, when the levels of this hormone also rise. The inference is that this hormone somehow affects the immune system for the better, and pre clinical studies have supported this idea. This study will test whether it is effective for uveitis when administered separately. This will be an interesting new addition to the current therapy for uveitis if it works. <<
p.s. My own ophthalmologist is an associate of Dr. Foster.
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.